Radiation (Standard)

RADIATION2 trials

Sponsors

Memorial Sloan Kettering Cancer Center, Ruijin Hospital

Conditions

Follicular LymphomaLymphoma of the Mucosa Associated Lymphoid Tissue (MALT)Marginal Zone Lymphoma

Phase 2

A Prospective Study of Response-adapted Low-dose Radiotherapy Combined With Orelabrutinib for Localized Mucosa-associated Lymphoid Tissue Extranodal Marginal Zone Lymphoma

Not yet recruitingNCT07705308

Ruijin HospitalLymphoma of the Mucosa Associated Lymphoid Tissue (MALT)

Start: 2026-08-01End: 2031-05-01Target: 140Updated: 2026-07-15

Phase 3

A Study of Reduced Dose Radiation Therapy for People With B-Cell Lymphomas

RecruitingNCT07029217

Memorial Sloan Kettering Cancer CenterFollicular Lymphoma, Marginal Zone Lymphoma

Start: 2025-06-09End: 2028-06-01Target: 375Updated: 2026-02-17